Eduardo Bruno Martins

CIK: 0001670431

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SGMT

Sagimet Biosciences Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

SGMT
Sagimet Biosciences Inc.
Feb 19, 2026
Award(A)
Direct
44K shares-
SGMT
Sagimet Biosciences Inc.
Feb 10, 2026
Sale(S)
Direct
3.6K shares at avg. $5.36$20K
SGMT
Sagimet Biosciences Inc.
Jul 21, 2025
Sale(S)
Direct
8.3K shares at avg. $9.13$76K
SGMT
Sagimet Biosciences Inc.
Feb 6, 2025
Award(A)
Direct
34K shares-

		Type	Shares	Price		Ownership
Feb 19, 2026	SGMT Sagimet Biosciences Inc.	Award(A)	44,000	-	$0	Direct
Feb 10, 2026	SGMT Sagimet Biosciences Inc.	Sale(S)	3,640	$5.36	$19,511	Direct
Jul 21, 2025	SGMT Sagimet Biosciences Inc.	Sale(S)	8,277	$9.13	$75,607	Direct
Feb 6, 2025	SGMT Sagimet Biosciences Inc.	Award(A)	34,000	-	-	Direct

1-4 of 4 transactions

About Martins Eduardo Bruno

Martins Eduardo Bruno (SEC CIK 0001670431) files insider reports with the SEC as Chief Medical Officer of Sagimet Biosciences Inc. (SGMT).

Signal8 holds 4 ownership filings by Martins Eduardo Bruno, all Form 4s, filed between Feb 7, 2025 and Feb 20, 2026. Those filings report 4 transactions, from Feb 6, 2025 to Feb 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Martins Eduardo Bruno's filings is in SAN MATEO, CA.

Recent filings by Martins Eduardo Bruno

Feb 19, 2026: Grant or award of SGMT shares (Form 4, code A).
Feb 10, 2026: Open-market sale of SGMT shares (Form 4, code S).
Jul 21, 2025: Open-market sale of SGMT shares (Form 4, code S).
Feb 6, 2025: Grant or award of SGMT shares (Form 4, code A).

Other insiders filing for Sagimet Biosciences Inc. (SGMT)

Kemble George, Director
Happel David, President & CEO
Rozek Elizabeth, Chief Legal & Admin. Officer
SEIDENBERG BETH C, Director
Hoelscher Paul W., Director
Jarrett Jennifer, Director

How to read Form 4 transaction codes